MYOS Corporation Stock Company Profile

Description

MYOS RENS Technology Inc., a bionutrition and biotherapeutics company, focuses on the discovery, development, and commercialization of nutritional and therapeutic products for maintaining and improving the health and performance of muscle tissue. The company primarily focuses on developing the products that improve muscle health and function essential to the management of sarcopenia, cachexia, and degenerative muscle diseases, and as an adjunct to the treatment of obesity. Its products include Fortetropin, a dietary supplement that has been shown in clinical studies to temporarily decrease the levels of serum myostatin; and MYO-T12, a proprietary formula containing Fortetropin and other ingredients for the sports nutrition market. The company was formerly known as MYOS Corporation and changed its name to MYOS RENS Technology Inc. in March 2016. MYOS RENS Technology Inc. was founded in 2007 and is based in Cedar Knolls, New Jersey.